HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

Brenda O’Connell(Infinity Pharmaceuticals (United States)), Jeffery L. Kutok(Infinity Pharmaceuticals (United States))

PLoS ONE

December 26, 2014

10.1371/journal.pone.0115228

Cited by 19

Related Papers

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies

|PLoS ONE|2018|29